Cyrano Therapeutics, Inc.
Records under this name other than the patents Cyrano Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 10 patents it holds.
Showing 1 to 6 of 6 · Back to Cyrano Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,670,849 | Method for diagnosing insulin resistance from nasal secretions Term ended Term ended May 1, 2026 · USPTO record | Term ended | Term ended May 1, 2026 | USPTO record |
| US 8,968,706 | Methods for Diagnosing and Treating Loss or Distortion of Taste Term ended Term ended May 1, 2026 · Medium confidence | Term ended | Term ended May 1, 2026 | Medium confidence |
| US 10,206,927 | Compostions and methods for treating chemosensory dysfunction Term ended Ended no later than May 1, 2026 · USPTO record | Term ended | Ended no later than May 1, 2026 | USPTO record |
| US 11,389,453 | Compositions and methods for treating chemosensory dysfunction Term ended Ended no later than May 1, 2026 · USPTO record | Term ended | Ended no later than May 1, 2026 | USPTO record |
| US 8,663,938 | Methods for detection of biological substances Lapsed on the fee record Ended Mar 4, 2026 · USPTO record | Lapsed on the fee record | Ended Mar 4, 2026 | USPTO record |
| US 8,506,934 | Methods for detection of biological substances Lapsed on the fee record Ended Aug 13, 2025 · USPTO record | Lapsed on the fee record | Ended Aug 13, 2025 | USPTO record |